Dr. Magdy Maksy, MD

Dr. Maksy practices at Toiyabe Dialysis Center - Bishop (N See Vee Ln) in Bishop, California.

Dr. Maksy's NPI, 1144334145, was assigned on August 18, 2006. Dr. Maksy graduated from Cairo University School of Medicine in 1973. Dr. Maksy holds California license A38931.

Dr. Maksy's primary practice is Toiyabe Dialysis Center - Bishop (N See Vee Ln), at 250 N See Vee Ln Ste B, Bishop, CA 93514. The practice phone is (760) 873-7611.

Dr. Maksy's primary practice is Toiyabe Dialysis Center - Bishop (N See Vee Ln) in Bishop, California. Dr. Maksy is also affiliated with Northern Inyo Hospital. The medical group on file is Commonwealth Healthcare Corporation. Dmand AI also links Dr. Maksy to 2 more hospitals, 1 community health center, 1 dialysis center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Maksy practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Maksy's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Maksy is board certified in diplomats;american board of obesity medicine by the ABOM. Dmand AI has Dr. Maksy's licenses on file in 3 states: California, Northern Mariana Islands and Virginia.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, kidney disease and parathyroid gland disorder among the conditions Dr. Maksy treats.

CMS data shows 326 Medicare services from Dr. Maksy across 3 procedure codes in 2024, for 153 Medicare patients. Medicare paid $47,635 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 153 Medicare patients who saw Dr. Maksy in 2024. The largest group is under 65, with 90 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 59% are also on Medicaid. Their average risk score is 7.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Maksy's median patient age at 67, with 54% women.

In 2024, Dr. Maksy wrote 692 Medicare Part D claims for 71 patients. 65% of them were for generic drugs. CMS names the drug for 466 of them, across 16 drugs with 11 or more claims each, at $84,130 in total drug cost. In 2023, CMS named 451 claims across 18 drugs.

Dr. Maksy accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Maksy. The most frequent topics are Renal Dialysis. Dr. Maksy's most frequent co-authors are Alan N Elias, MD, Madeleine V. Pahl, MD and Nosratola D. Vaziri, MD.

CMS Open Payments shows 20 general payments to Dr. Maksy from 9 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Fresenius USA Marketing, Inc. paid the most, $495.

Dmand AI lists 1 award for Dr. Maksy, most recently CMS Stage 1 EHR in 2013.

Dr. Maksy graduated from Cairo University School of Medicine in 1973.

Dr. Maksy is in network with 7 carriers, including Blue Cross Blue Shield of Massachusetts, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.